# Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery

> **NCT01923129** · NA · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 142 (actual)

## Conditions studied

- Urinary Retention

## Interventions

- **DRUG:** Prazosin given 6 hours prior to catheter removal in the 24 hour group

## Key facts

- **NCT ID:** NCT01923129
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-30
- **Primary completion:** 2017-11-22
- **Final completion:** 2017-11-22
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2019-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01923129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01923129, "Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01923129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*